Catalyst

Slingshot members are tracking this event:

PDUFA for Stelara (ustekinumab) Adult patients with moderate-to-severe Crohn's set for Sept 2016

Source Link:
http://www.jnj.com/news/all/Janssen-Submits-Applications-Seeking-Approval-Of-STELARA-In-United-States-And-European-Union-For-Crohns-Disease

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 26, 2016
Occurred Source:
http://seekingalpha.com/pr/16615571-fda-approves-stelara-ustekinumab-treatment-adults-moderately-severely-active-crohns-disease
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Ustekinumab, Crohn's Disease
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.